Evolutionary Genomics

Evolutionary Genomics Current Assets

The Current Assets of Evolutionary Genomics (FNAM) as of Nov 18, 2026 is 620,913.00 USD. In the previous year, Current Assets was 255,801.00 USD — a change of 142.73% (higher).

Current Assets

620,913.00USD

YoY

142.73%

Last updated:

Current Assets of Evolutionary Genomics is 2022 620,913.00 USD. Current Assets of Evolutionary Genomics was 2021 255,801.00 USD. It decreases by 142.73% higher compared to the previous year.

The Evolutionary Genomics Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2015
42,117.00 USD
Jan 1, 2016
2.09 M USD
Jan 1, 2017
1.19 M USD
Jan 1, 2018
223,378.00 USD
Jan 1, 2019
118,218.00 USD
Jan 1, 2020
277,593.00 USD
Jan 1, 2021
255,801.00 USD
Jan 1, 2022
620,913.00 USD
The Evolutionary Genomics Current Assets history
YEARCurrent AssetsYoY
620,913.00USD+142.73%
255,801.00USD-7.85%
277,593.00USD+134.81%
118,218.00USD-47.08%
223,378.00USD-81.28%
1.19 MUSD-42.90%
2.09 MUSD+4,860.61%
42,117.00USD-91.84%
516,224.00USD-518.09%
-123,473.00USD-19,066.67%
651.00USD+78.85%
364.00USD-0.27%
365.00USD-98.07%
18,950.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings. Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

Current Assets of Evolutionary Genomics is 620,913.00 USD in 2022.

Current Assets of Evolutionary Genomics changed from 255,801.00 USD to 620,913.00 USD, representing a 142.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Evolutionary Genomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Evolutionary Genomics

All Key Metrics — Evolutionary Genomics